Expression of Functional Na,K-ATPase Isozymes in Normal Human Cardiac Biopsies
Overview
Authors
Affiliations
In human heart failure, disturbances in Ca2+ homeostasis are well known but the fate of the Na,K-ATPase isoforms (alpha1beta1, alpha2beta1 and alpha3beta1), the receptors for cardiac glycosides, still remains under study. Microsomes have been purified from non-failing human hearts. As judged by the sensitivities of Na,K-ATPase activity to ouabain (IC50 values: 7.0 +/- 2.5 and 81 +/- 11 nM), 3H-ouabain-binding measurements at equilibrium with and without 10 mM K+ and by a biphasic ouabain dissociation process, at least two finctionally active Na,K-ATPase isozymes coexist in normal human hearts. These are demonstrated as a very high- and a high affinity ouabain-binding site. The KD values are 3.6 +/- 1.6 nM and 17 +/- 6 nM, respectively. The two dissociation rate constants are 42 x 10(4) min(-1) and 360 x 10(-4) min(-1). Addition of 10 mM K+ ions shifted the respective KD values for ouabain from 3.6 +/- 1.6 to 20 +/- 5 nM and from 17 +/- 6 nM to 125 +/- 25 nM, respectively. The isozymes involved are identified by comparing these three pharmacological parameters to those of each alpha/beta-isozyme separately expressed in Xenopus oocytes (9). In human heart, the very high affinity site for ouabain is the alpha1beta1 dimer and the high affinity site is alpha2beta1.
The sodium pump and digitalis drugs: Dogmas and fallacies.
Askari A Pharmacol Res Perspect. 2019; 7(4):e00505.
PMID: 31360524 PMC: 6639696. DOI: 10.1002/prp2.505.
Orellana A, Garcia-Gonzalez V, Lopez R, Pascual-Guiral S, Lozoya E, Diaz J PLoS One. 2018; 13(1):e0189247.
PMID: 29320511 PMC: 5761851. DOI: 10.1371/journal.pone.0189247.
Regulation of Cardiac Remodeling by Cardiac Na(+)/K(+)-ATPase Isoforms.
Liu L, Wu J, Kennedy D Front Physiol. 2016; 7:382.
PMID: 27667975 PMC: 5016610. DOI: 10.3389/fphys.2016.00382.
Surovtseva Y, Jairam V, Salem A, Sundaram R, Bindra R, Herzon S J Am Chem Soc. 2016; 138(11):3844-55.
PMID: 26927829 PMC: 5530877. DOI: 10.1021/jacs.6b00162.
Weiss M, Kang W Pharm Res. 2004; 21(2):231-6.
PMID: 15032303 DOI: 10.1023/b:pham.0000016236.36210.a6.